中文
Earlier issues
Announcement
More
Progress in Chemistry 2013, Vol. 25 Issue (09): 1415-1420 DOI: 10.7536/PC121262 Previous Articles   Next Articles

Cancer Epidemiology and Control in China：State of the Art

Zeng Hongmei, Chen Wanqing*   

  1. National Office for Cancer Prevention and Control, Chinese Academy of Medical Sciences, Cancer Hospital & Institute, Beijing 100021, China
  • Received: Revised: Online: Published:
Richhtml ( 18 ) PDF ( 5584 ) Cited
Export

EndNote

Ris

BibTeX

Cancer has been a major challenge for public health in China. It ranks first among all causes of death in urban areas, and second in rural areas. This paper present the latest cancer statistics of China. The incident number of gastrointestinal cancers is still high and the burden of lung cancer and breast cancer are increasing. The trend indicates that the overall cancer burden would still be severe with the rapid development of China and aging population. Addressing this challenge requires comprehensive and multidisciplinary approaches. The current status of cancer control polices, structures, and cancer registration in China are described. National cancer control plans has been carried out by Ministry of Health since 1986. National program of cancer registry has been set up. In 2012, the number of population-based cancer registries has expanded to 222, covering populations with 200 millions. In areas with high risk of cancer, they have held systematic programs of cancer control. Many places such as Linzhou and Cixian have shown a down-trend of cancer incidence and mortality. The successful experiences in areas of high risk of cancer also promote the nationwide cancer campaign. The prevention programs include tobacco control, immunization against hepatitis B for infants and children, and cancer early detection and diagnosis. This paper provides considerable scope and motivation for future work on cancer control and prevention.

Contents
1 Introduction
2 Cancer statistics
3 The current status of cancer prevention and control
3.1 Strategies and policies for cancer control and prevention
3.2 Systematic construction for cancer related agencies
3.3 Cancer registry and surveillance
3.4 Experiences of cancer control in areas with high risk of cancer
3.5 Nationwide cancer control programs
4 Conclusion and outlook

Key words: cancer, trend analysis, prevention and control, cancer screening

CLC Number: 

[1] 陈竺(Chen Z). 全国第三次死因回顾抽样调查报告(The Third National Death Survey Report). 北京:中国协和医科大学出版 社(Beijing: Peking Union Medical College Publication House), 2008. 11—12
[2] Wang J B, Jiang Y, Liang H, Li P, Xiao H J, Ji J, Xiang W, Shi J F, Fan Y G, Li L, Wang D, Deng S S, Chen W Q, Wei W Q, Qiao Y L, Boffetta P. Ann. Oncol., 2012, 23(11): 2983—2989
[3] 赫捷(He J), 陈万青(Chen W Q). 2012年中国肿瘤登记年报 (Chinese Cancer Registry Annual Report 2012). 北京:军事医学 科学出版社(Beijing: Press of Military Medical Sciences), 2012. 21—39
[4] 陈万青(Chen W Q),郑荣寿(Zheng R S),曾红梅(Zeng H M), 张思维(Zhang S W),赵平(Zhao P),赫捷(He J). 中华肿瘤杂 志(Chinese Journal of Oncology), 2012, 34(7): 517—524
[5] 曾红梅(Zeng H M),郑荣寿(Zheng R S),张思维(Zhang S W),赵平(Zhao P),赫捷(He J),陈万青(Chen W Q). 中华肿 瘤杂志(Chinese Journal of Oncology), 2012, 34(7): 525—531
[6] 陈万青(Chen W Q), 邹小农(Zou X N). 中国肿瘤(China Cancer), 2008, 17(9): 794—796
[7] 中国慢性病防治工作规划(2012—2015年). National Program for Chronic Disease Control and Prevention (2012—2015)[2012-12-24]. http://www.moh.gov.cn/publicfiles/business/ htmlfiles/mohjbyfkzj/s5878/201205/54755.htm.
[8] 中国癌症防治行动计划调研组(Investigation Group of Action Plan for Cancer Prevention and Control in China). 中国肿瘤 (China Cancer), 2012, 21(9): 641—643
[9] 陈竺(Chen Z). 中国卫生产业(China Health Industry), 2012, 9(1): 2
[10] 唐辉(Tang H),马洁(Ma J). 癌症进展(Cancer Progress), 2010, 8(2): 202—204
[11] 张思维(Zhang S W), 陈万青(Chen W Q), 王乐(Wang L). 中国 肿瘤(China Cancer), 2009, 18(4): 256—259
[12] 游伟程(You W C). 中国肿瘤(China Cancer), 2011, 20(1): 14—17
[13] You W C, Brown L M, Zhang L, Li J Y, Jin M L, Chang Y S, Ma J L, Pan K F, Liu W D, Hu Y, Crystal-Mansour S, Pee D, Blot W J, Fraumeni J F Jr, Xu G W, Gail M H. J. Natl. Cancer Inst., 2006, 98(14): 974—983
[14] Ma J L, Zhang L, Brown L M, Li J Y, Shen L, Pan K F, Liu W D, Hu Y, Han Z X, Crystal M S, Pee D, Blot W J, Fraumeni J F Jr, You W C, Gail M H. J. Natl. Cancer Inst., 2012, 104(6):488—492
[15] Wong B C Y, Zhang L, Ma J L, Pan K F, Li J Y, Shen L, Liu W D, Feng G S, Zhang X D, Li J, Lu A P, Xia H H, Lam S, You W C. Gut, 2012, 61(6): 812—818
[16] Qiao Y L, Dawsey S M, Kamangar F, Fan J H, Abnet C C, Sun X D, Johnson L L, Gail M H, Dong Z W, Yu B, Mark S D, Taylor P R. J. Natl. Cancer Inst., 2009, 101(7): 507—518
[17] Limburg P J, Wei W, Ahnen D J, Qiao Y, Hawk E T, Wang G, Giffen C A, Wang G, Roth M J, Lu N, Korn E L, Ma Y, Caldwell K L, Dong Z, Taylor P R, Dawsey S M. Gastroenterology, 2005, 129(3): 863—873
[18] Blot W J, Li J Y, Taylor P R, Guo W, Dawsey S, Wang G Q, Yang C S, Zheng S F, Gail M, Li G Y, Yu Y, Liu B Q, Tangrea J, Sun Y H, Liu F S, Fraumeni J F, Zhang Y H Jr, Li B. J. Natl. Cancer Inst., 1993, 85(18): 1483—1492
[19] 董志伟(Dong Z W), 乔友林(Qiao Y L), 王贵齐(Wang G Q), 张 苏展(Zhang S Z), 游伟程(You W C), 钱耕荪(Qian S G), 唐步坚 (Tang B J), 周清华(Zhou Q H), 李纪宾(Li J B), 杨娟(Yang J), 李 光琳(Li G L), 吴良有(Wu L Y), 孔灵芝(Kong L Z). 中华肿瘤杂 志(Chinese Journal of Oncology), 2012, 34(8): 637—640
[20] 陈建国(Chen J G), 朱健(Zhu J), 张永辉(Zhang Y H), 陈永胜 (Chen Y S), 丁璐璐(Ding L L), 陆建华(Lu J H), 朱源荣(Zhu Y R). 中华肿瘤杂志(Chinese Journal of Oncology), 2012, 34(7): 532—537
[21] 刘曙正(Liu S Z), 戴涤新(Dai D X), 连士勇(Lian S Y), 李变云(Li B Y). 中国肿瘤(China Cancer), 2008, 17(4): 278—280
[22] Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler S C, Wang Y. J. Infect. Dis., 2009, 200(1): 39—47
[23] Li J, Kang L N, Qiao Y L. Asian Pac. J. Cancer Prev., 2011, 12(5): 1149—1153
[24] Zhu F C, Li C G, Pan H X, Zhang Y J, Bi D, Tang H W, Datta S. Chin. J. Cancer, 2011, 30(8): 559—564
[25] 卫生部疾病预防控制局癌症早诊早治项目专家委员会 (Academic Board on Cancer Screening and Early Diagnosis, Bureau of Disease Control and Prevention, Ministry of Health)． 癌症早诊早治项目技术方案(2011年版)(Technical Scheme of Cancer Early Detection and Diagnosis, 2011)．北京:人民卫生 出版社(Beijing: People's Medical Publishing House), 2011
[1] Dang Zhang, Xi Wang, Lei Wang. Biomedical Applications of Enzyme-Powered Micro/Nanomotors [J]. Progress in Chemistry, 2022, 34(9): 2035-2050.
[2] Xiaodong Jing, Ying Sun, Bing Yu, Youqing Shen, Hao Hu, Hailin Cong. Rational Design of Tumor Microenvironment Responsive Drug Delivery Systems [J]. Progress in Chemistry, 2021, 33(6): 926-941.
[3] Jiajia Wang, Huiying Wu, Renfeng Dong, Yuepeng Cai. Micro/Nanomotors on the Way to Intelligent Cancer Diagnosis, Delivery and Therapy [J]. Progress in Chemistry, 2021, 33(5): 883-894.
[4] Yunxue Wu, Hengyi Zhang, Yu Liu. Application of Azobenzene Derivative Probes in Hypoxia Cell Imaging [J]. Progress in Chemistry, 2021, 33(3): 331-340.
[5] Shan Guo, Xiang Zhou. Detection of Circulating Tumor Cell in Vivo:Technology and Application [J]. Progress in Chemistry, 2021, 33(1): 1-12.
[6] Ziru Sun, Shengnan Liu, Qingzhi Gao. Development of Anticancer Drugs Targeting Glucose Transporters(GLUTs) [J]. Progress in Chemistry, 2020, 32(12): 1869-1878.
[7] Xinyi Lai, Zhiyong Wang, Yongtai Zheng, Yongming Chen. Nanoscale Metal Organic Frameworks for Drug Delivery [J]. Progress in Chemistry, 2019, 31(6): 783-790.
[8] Bingde Zheng, Yuanyuan Zhao, Hongcai Li, Biyuan Zheng, Meirong Ke, Jiandong Huang*. Activatable Photodynamic Anticancer Photosensitizers [J]. Progress in Chemistry, 2018, 30(9): 1403-1414.
[9] Liang He, Caiping Tan, Qian Cao, Zongwan Mao. Application of Phosphorescent Cyclometalated Iridium(Ⅲ) Complexes in Cancer Treatment [J]. Progress in Chemistry, 2018, 30(10): 1548-1556.
[10] Juan Shen, Yang Zhu, Hongdong Shi, Yangzhong Liu. Multifunctional Nanodrug Delivery Systems for Platinum-Based Anticancer Drugs [J]. Progress in Chemistry, 2018, 30(10): 1557-1572.
[11] Gong Zhaocui, Yin Chao, Zhao Hui, Lu Xiaomei, Fan Quli, Huang Wei. Light-Controlled Nanocarriers for Drug Release [J]. Progress in Chemistry, 2016, 28(9): 1387-1396.
[12] Jiang Ge, Luo Feng, Xu Yaozhong, Zhang Xiaohui. UVA Assisted 4-Thiothymidine for Cancer Treatment [J]. Progress in Chemistry, 2016, 28(8): 1224-1237.
[13] Zheng Xiaohui, Xia Lixin, Mao Zongwan. The New Anticancer Platinum Complex Designed on the Basis of Nucleic Acid [J]. Progress in Chemistry, 2016, 28(7): 1029-1038.
[14] Ye Jiqing, Yue Xiaohong, Sun Liping. Small Molecule Inhibitors of IL-6/STAT3 Signaling [J]. Progress in Chemistry, 2016, 28(7): 1099-1111.
[15] Huang Di, Xiang Nan, Tang Wenlai, Zhang Xinjie, Ni Zhonghua. Microfluidics-Based Circulating Tumor Cells Separation [J]. Progress in Chemistry, 2015, 27(7): 882-912.